The European Commission (EC) has approved sugemalimab (brand name: Cejemly®) in combination with platinum-based chemotherapy for the first-line treatment of patients with metastatic NSCLC with no ...
A surge in devotees visiting the Ram Janmbhoomi Temple in Ayodhya has led authorities to tighten security measures The influx is attributed to the ongoing Maha ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback